http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33619915

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 273
issn 1043-6618
issueIdentifier 3
pageRange 268-273
publicationName Pharmacological Research
startingPage 268
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4c34dbb90878b3d81da573f437e615c3
bibliographicCitation Thirstrup K, Christensen S, Møller HA, Ritzén A, Bergström AL, Sager TN, Jensen HS. Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors. Pharmacol Res. 2011 Sep;64(3):268–73. doi: 10.1016/j.phrs.2011.03.017. PMID: 21504793.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f262dd18c32b751fb3d7bcef8b1d4d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_209d2f23cc6c964467904261e3e4b31c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4ba13183301319b38304408287d8d34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f85c4109948f5e62c744ff9934f6141e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d7f78afd58ae9b27a757ca719732af5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3dfbe4fedf6cb5f7334743d960120bf9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2500-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a690d8f9c64ef9f93a6e986ff1b7d380
date 201109
identifier https://doi.org/10.1016/j.phrs.2011.03.017
https://pubmed.ncbi.nlm.nih.gov/21504793
isPartOf https://portal.issn.org/resource/ISSN/1043-6618
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6565
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors
discusses http://id.nlm.nih.gov/mesh/M0465565
http://id.nlm.nih.gov/mesh/M0471842
http://id.nlm.nih.gov/mesh/M0017694
http://id.nlm.nih.gov/mesh/M0007520
http://id.nlm.nih.gov/mesh/M0464092
http://id.nlm.nih.gov/mesh/M0015042
http://id.nlm.nih.gov/mesh/M0415674
http://id.nlm.nih.gov/mesh/M0584225
http://id.nlm.nih.gov/mesh/M0011991
http://id.nlm.nih.gov/mesh/M0018641
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D049308Q000378
http://id.nlm.nih.gov/mesh/D007656Q000378
http://id.nlm.nih.gov/mesh/D004791Q000494
http://id.nlm.nih.gov/mesh/D011393Q000378
http://id.nlm.nih.gov/mesh/D009687Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002460
http://id.nlm.nih.gov/mesh/D011994Q000235
http://id.nlm.nih.gov/mesh/D049308Q000235
http://id.nlm.nih.gov/mesh/D011393Q000235
http://id.nlm.nih.gov/mesh/D011994Q000378
http://id.nlm.nih.gov/mesh/D049308Q000037
http://id.nlm.nih.gov/mesh/D009687Q000235
http://id.nlm.nih.gov/mesh/D004353Q000379
http://id.nlm.nih.gov/mesh/D009687Q000037
http://id.nlm.nih.gov/mesh/D064799
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011994Q000037
http://id.nlm.nih.gov/mesh/D011393Q000037
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7052f494ab453fc658190f21b0b759bf
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.14.11.2
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eccf049aa36d3f33af63ae3955286577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d7da0315ee5260fd1e4ae3ff0178308
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57461922
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0b445aa509d2f8389fc3f165568c3dde
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57465876
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127702064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128415257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135855964

Total number of triples: 69.